Form 4: DocuSign CLO Sells DOCU Shares via 10b5-1 Plan
Insider Transaction Report
DocuSign's Chief Legal Officer, James P. Shaughnessy, sold 7,500 shares of common stock for approximately $534,111 under a pre-arranged 10b5-1 trading plan.
Summary
- James P. Shaughnessy, DocuSign's Chief Legal Officer, disposed of a total of 7,500 shares of common stock.
- The transactions occurred on October 1, 2025, pursuant to a Rule 10b5-1 trading plan.
- The shares were sold in two separate transactions: 1,918 shares at an average price of $70.71 per share (ranging from $70.05 to $70.97) and 5,582 shares at an average price of $71.36 per share (ranging from $71.00 to $71.75).
- The total value of the shares sold was approximately $534,111.90.
- Following these transactions, James P. Shaughnessy beneficially owns 55,442 shares of DocuSign common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a pre-planned sale under a Rule 10b5-1 plan, which is a routine event for insiders and does not typically indicate a change in management's outlook on the company's prospects.
Positives
- The sale was conducted pursuant to a pre-arranged Rule 10b5-1 trading plan, indicating a scheduled, non-discretionary transaction rather than a reaction to new material non-public information.
Negatives
- A reduction in insider ownership by 7,500 shares, representing a decrease in the Chief Legal Officer's direct stake in the company.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing reports a routine insider stock transaction and does not provide information relevant to broader industry trends or competitive analysis.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Plan | The transaction was executed under a Rule 10b5-1 plan, which allows insiders to set up a pre-scheduled plan to buy or sell company stock to avoid accusations of insider trading. | 10/01/2025 | Enhances transparency and reduces the perception of opportunistic insider selling, aligning with good corporate governance practices. |
Stakeholder Impact
- Shareholders will observe a reduction in the Chief Legal Officer's direct beneficial ownership of DocuSign common stock.
Key Dates
| Date | Description |
|---|---|
| 10/01/2025 | Date of earliest transaction (sale of common stock). |
| 10/02/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdA routine insider sale executed under a pre-arranged Rule 10b5-1 plan typically does not provide new fundamental information that would warrant a change in investment recommendation. Such sales are often for personal financial planning, diversification, or tax purposes and are not usually indicative of management's view on the company's immediate future performance. Investors should consider broader company fundamentals and market conditions rather than this single transaction.
Keywords
DocuSign, DOCU, Insider Trading, Form 4, Stock Sale, James P Shaughnessy, Chief Legal Officer, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.